BlackRock
MXCT icon

BlackRock’s MaxCyte MXCT Stock Holding History

BlackRock’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.18M Sell
8,798,473
-444,114
-5% -$415K ﹤0.01% 3745
2025
Q4 		$14.3M Sell
9,242,587
-741,326
-7% -$1.18M ﹤0.01% 3279
2025
Q3 		$15.8M Sell
9,983,913
-218,330
-2% -$379K ﹤0.01% 3231
2025
Q2 		$22.2M Buy
10,202,243
+2,033,867
+25% +$4.92M ﹤0.01% 2957
2025
Q1 		$22.3M Buy
8,168,376
+144,936
+2% +$571K ﹤0.01% 2865
2024
Q4 		$33.4M Sell
8,023,440
-464,667
-5% -$1.76M ﹤0.01% 2713
2024
Q3 		$33M Buy
8,488,107
+345,743
+4% +$1.46M ﹤0.01% 2723
2024
Q2 		$31.9M Buy
8,142,364
+912,791
+13% +$3.93M ﹤0.01% 2706
2024
Q1 		$30.3M Sell
7,229,573
-111,813
-2% -$525K ﹤0.01% 2753
2023
Q4 		$34.5M Buy
7,341,386
+453,390
+7% +$1.77M ﹤0.01% 2711
2023
Q3 		$21.5M Sell
6,887,996
-32,088
-0.5% -$129K ﹤0.01% 2903
2023
Q2 		$31.8M Sell
6,920,084
-100,577
-1% -$462K ﹤0.01% 2754
2023
Q1 		$34.8M Buy
7,020,661
+205,579
+3% +$1.01M ﹤0.01% 2679
2022
Q4 		$37.2M Buy
6,815,082
+367,139
+6% +$2.25M ﹤0.01% 2671
2022
Q3 		$41.9M Buy
6,447,943
+784,524
+14% +$4.38M ﹤0.01% 2577
2022
Q2 		$26.8M Buy
5,663,419
+219,582
+4% +$1.08M ﹤0.01% 2922
2022
Q1 		$38.1M Buy
5,443,837
+229,373
+4% +$1.57M ﹤0.01% 2741
2021
Q4 		$53.1M Buy
5,214,464
+4,535,552
+668% +$48.7M ﹤0.01% 2624
2021
Q3 		$8.29M Buy
+678,912
New +$10.2M ﹤0.01% 3756

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock's MXCT Position: Q1 2026 in Review

BlackRock reduced its MaxCyte (MXCT) stake by 4.8% in Q1 2026, selling an estimated $415K and leaving 8,798,473 shares worth $6.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3745.

BlackRock first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $53.1M in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • BlackRock held 8,798,473 shares of MaxCyte worth $6.18M as of Q1 2026.
  • BlackRock sold 444,114 MaxCyte shares in Q1 2026, an estimated $415K.
  • MaxCyte made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3745 holding.
  • BlackRock first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • BlackRock's MaxCyte position peaked at $53.1M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.